NATALIE OREY: Open Payments
NPI 1508295973 · WYOMING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$614 in 29 payments from 12 companies in 2025. Trend: 2023 $24 · 2024 $77 · 2025 $614
Food & beverage: $614
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $169 |
| Ipsen Biopharmaceuticals, Inc | 3 | $86 |
| Novo Nordisk Inc | 3 | $76 |
| Janssen Biotech, Inc. | 2 | $53 |
| Ardelyx, Inc. | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 3 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Madrigal Pharmaceuticals | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
Products named: IQIRVO, RINVOQ, Wegovy, TREMFYA, CREON, IBSRELA, VOQUEZNA, ENTYVIO.
Industry payments across MI — which companies pay providers there.
